Bindu Sathi
Pediatric Hematology-Oncology · Stockton, CANPI 1093872483
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $76,318 of the $77,867 with a category attached, or 98.0%. Vertex accounts for 95.3% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2022 at $24,246 and has fallen 55.0% since, to $10,920 in 2025. Among pediatric hematology-oncology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 96 payments — averaging $811.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$74K
- Global Blood Therapeutics, Inc.$2K
- AstraZeneca$320
- Novo Nordisk$262
- Novartis$182
- Shire North American Group Inc$122
- plus $575 from 18 others
What the payments were for
- Consulting fees$76,31898%
- Speaking & faculty fees$1500%
- Food & beverage$1,3142%
- Education$850%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 48 | $74,200 |
| Global Blood Therapeutics, Inc. | 3 | $2,206 |
| AstraZeneca | 6 | $320 |
| Novo Nordisk | 7 | $262 |
| Novartis | 4 | $182 |
| Shire North American Group Inc | 1 | $122 |
| Pfizer | 3 | $72 |
| Pharming Healthcare, Inc. | 3 | $66 |
| Chiesi USA, Inc. | 3 | $56 |
| Sobi, Inc | 2 | $50 |
| CSL Behring | 2 | $40 |
| HEMA Biologics, LLC | 2 | $39 |
| Genentech, Inc. | 1 | $32 |
| Rhythm Pharmaceuticals, Inc. | 1 | $29 |
| RARE Disease Therapeutics, Inc. | 1 | $25 |
| Biomarin Pharmaceutical Inc. | 1 | $24 |
| Apellis Pharmaceuticals, Inc. | 1 | $21 |
| Bayer | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| UCB, Inc. | 1 | $19 |
| Genetix Biotherapeutics Inc | 1 | $19 |
| Grifols USA, LLC | 1 | $16 |
| Emmaus Medical, Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$77,867 in reported general payments places this provider in the 90th percentile of 307 pediatric hematology-oncology providers in California.
See all pediatric hematology-oncology providers in California →
Other pediatric hematology-oncology in Stockton
- Philip PizzoPalo Alto$2.6M
- Vinod BalasaMadera$508K
- Akshat JainRedlands$447K
- Noah FedermanLos Angeles$399K
- Vanessa Salinas-LunaOrange$344K
- Daniel KraftStanford$294K
- Arash MahajerinOrange$249K
- Elysia AlvarezPalo Alto$200K
- Christopher DvorakPalo Alto$144K
- Jan van TornoutLos Angeles$137K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.